drugset / Trial / NCT02487485
Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects
RandomizedCrossoverTriple-blindOther
Summary
The aim of the study is to provide insight into the impact of the immunosuppressant drug sirolimus, on the antidepressant effects of the prototypal rapid-acting antidepressant medication, ketamine.
Timeline
- Start
- 2016-03
- Primary completion
- 2020-01
- Completion
- 2020-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.5 mg/kg | Intravenous |
| Subject | Sirolimus | Small molecule | 6 mg | Oral |